Boston Scientific Corporation (BSX Quick QuoteBSX ) is scheduled to report third-quarter 2022 results on Oct 26, before the opening bell.

In the last reported quarter, the company’s earnings per share of 44 cents exceeded the Zacks Consensus Estimate by 4.8%. BSX’s bottom line beat estimates in each of the trailing four quarters. The company has a trailing four-quarter earnings surprise of 3.04%, on average.

Factors at Play

Boston Scientific expects third-quarter 2022 operational revenue growth in the range of 10% to 12% year over year. This....More>>>

Though smaller companies have lagged behind bigger ones, they are staging a recovery and could be well-positioned to keep going—especially if the latest concerns about the economic recovery ease.

For investors looking for a way to tap into the prospects for smaller companies, active funds may be an option since many are beating the index.

After the market clocked another high and megacap technology companies hold firm to their dominance, some investors are looking to diversify.

One way is to pay more attention to smaller companies. Small-cap valuations, using....More>>>